Skip to main content

Thrombolysis

  • Reference work entry
  • First Online:
Encyclopedia of Clinical Neuropsychology
  • 9 Accesses

Synonyms

Clot busting; Fibrinolysis

Definition

Thrombolysis is the breakdown or “lysis” of blood clots, usually induced by using pharmacological agents.

Current Knowledge

Its actions occur by stimulating a component of the body’s inherent natural clot breakdown mechanism known as “fibrinolysis” normally caused by the enzyme plasmin. This process is implemented by infusing into the body, usually intravenously, drugs that mimic tissue plasminogen activator, the protein that normally and naturally activates plasmin. The most frequently studied and commonly used drug used to activate plasmin, thereby causing fibrinolysis and breaking down thrombi, is recombinant tissue plasminogen activator (rTPA). This medication (commonly called a “clot buster”) is used during the acute phase to treat ischemic stroke but has been found to be effective only when administered within the first few hours following onset of stroke. It breaks the thrombus that occludes the vessel causing the stroke and thereby...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Davalos, A., Guidetti, D., Larrue, V., Less, K. R., Medeghri, Z., Machnig, T., Schneider, D., von Kummer, R., Wahlgren, N., Toni, D., et al. (2008). Thrombolysis with Alteplase 3 to 4.5 hours after acute ischemic stroke. New England Journal of Medicine, 359, 1317–1329.

    Article  PubMed  Google Scholar 

  • Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., Jauch, E. C., Kidwell, C. S., Leslie-Mazwi, T. M., Ovbiagele, B., Scott, P. A., Sheth, K. N., Southerland, A. M., Summers, D. V., Tirschwell, D. L., & on behalf of the American Heart Association Stroke Council. (2018). Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018, 49, eXXX–eXXX. https://doi.org/10.1161/STR.0000000000000158.

    Article  Google Scholar 

  • Wardlaw, J. M., Murray, V., Berge, E., & Del Zoppo, G. J. (2014). Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews, 7, CD000213.

    Google Scholar 

  • Wechsler, L. R. (2011). Intravenous thrombolytic therapy for acute ischemic stroke. New England Journal of Medicine, 364(22), 2138–2146.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elliot J. Roth .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Roth, E.J. (2018). Thrombolysis. In: Kreutzer, J.S., DeLuca, J., Caplan, B. (eds) Encyclopedia of Clinical Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-57111-9_2204

Download citation

Publish with us

Policies and ethics